KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis
Europe - AMS:PHIA - NL0000009538 - Common Stock
24.09 EUR
-0.22 (-0.9%)
Overall PHIA gets a fundamental rating of 3 out of 10. We evaluated PHIA against 63 industry peers in the Health Care Equipment & Supplies industry. PHIA has a bad profitability rating. Also its financial health evaluation is rather negative. PHIA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year PHIA was profitable.
PHIA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
PHIA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a Return On Assets value of 0.61%, PHIA is not doing good in the industry: 63.49% of the companies in the same industry are doing better.
The Return On Equity of PHIA (1.56%) is worse than 63.49% of its industry peers.
With a Return On Invested Capital value of 4.27%, PHIA perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROIC | 4.27% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHIA's Profit Margin of 0.91% is on the low side compared to the rest of the industry. PHIA is outperformed by 65.08% of its industry peers.
PHIA has a Operating Margin (6.11%) which is comparable to the rest of the industry.
PHIA's Operating Margin has declined in the last couple of years.
PHIA has a worse Gross Margin (43.85%) than 71.43% of its industry peers.
In the last couple of years the Gross Margin of PHIA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHIA is destroying value.
PHIA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for PHIA has been increased compared to 5 years ago.
Compared to 1 year ago, PHIA has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 1.94 indicates that PHIA is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.94, PHIA is in line with its industry, outperforming 44.44% of the companies in the same industry.
PHIA has a debt to FCF ratio of 19.41. This is a negative value and a sign of low solvency as PHIA would need 19.41 years to pay back of all of its debts.
PHIA has a Debt to FCF ratio (19.41) which is in line with its industry peers.
A Debt/Equity ratio of 0.69 indicates that PHIA is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.69, PHIA is doing worse than 73.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Altman-Z | 1.94 |
ROIC/WACC0.64
WACC6.7%
2.3 Liquidity
A Current Ratio of 1.26 indicates that PHIA should not have too much problems paying its short term obligations.
PHIA has a worse Current ratio (1.26) than 61.90% of its industry peers.
PHIA has a Quick Ratio of 1.26. This is a bad value and indicates that PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
PHIA has a Quick ratio of 0.81. This is in the lower half of the industry: PHIA underperforms 61.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
PHIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.17%, which is quite good.
The Earnings Per Share has been decreasing by -7.17% on average over the past years.
The Revenue has decreased by -1.53% in the past year.
Measured over the past years, PHIA shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)11.17%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%21.91%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-2.12%
3.2 Future
Based on estimates for the next years, PHIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.26% on average per year.
PHIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.26% yearly.
EPS Next Y0.42%
EPS Next 2Y5.48%
EPS Next 3Y7.81%
EPS Next 5Y12.26%
Revenue Next Year-1.83%
Revenue Next 2Y0.64%
Revenue Next 3Y1.91%
Revenue Next 5Y3.26%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 16.73, which indicates a correct valuation of PHIA.
Based on the Price/Earnings ratio, PHIA is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
PHIA is valuated rather cheaply when we compare the Price/Earnings ratio to 27.29, which is the current average of the S&P500 Index.
PHIA is valuated correctly with a Price/Forward Earnings ratio of 15.63.
76.19% of the companies in the same industry are more expensive than PHIA, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.85, PHIA is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.73 | ||
| Fwd PE | 15.63 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PHIA is valued a bit cheaper than the industry average as 76.19% of the companies are valued more expensively.
PHIA's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.45 | ||
| EV/EBITDA | 12.58 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHIA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)40.31
PEG (5Y)N/A
EPS Next 2Y5.48%
EPS Next 3Y7.81%
5. Dividend
5.1 Amount
PHIA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMS:PHIA (10/17/2025, 11:42:27 AM)
24.09
-0.22 (-0.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners47.54%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap23.20B
Analysts74.81
Price Target27.28 (13.24%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)-0.47%
PT rev (3m)4.09%
EPS NQ rev (1m)-0.38%
EPS NQ rev (3m)-3.82%
EPS NY rev (1m)-0.76%
EPS NY rev (3m)-8.66%
Revenue NQ rev (1m)-0.38%
Revenue NQ rev (3m)-3.42%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-2.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.73 | ||
| Fwd PE | 15.63 | ||
| P/S | 1.3 | ||
| P/FCF | 53.45 | ||
| P/OCF | 21.11 | ||
| P/B | 2.23 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.58 |
EPS(TTM)1.44
EY5.98%
EPS(NY)1.54
Fwd EY6.4%
FCF(TTM)0.45
FCFY1.87%
OCF(TTM)1.14
OCFY4.74%
SpS18.54
BVpS10.78
TBVpS-1.76
PEG (NY)40.31
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROCE | 5.69% | ||
| ROIC | 4.27% | ||
| ROICexc | 4.72% | ||
| ROICexgc | 15.5% | ||
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% | ||
| FCFM | 2.43% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y10.6%
ROICexcg growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Debt/EBITDA | 3.01 | ||
| Cap/Depr | 51.35% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 4 | ||
| Cash Conversion | 46.06% | ||
| Profit Quality | 267.9% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 1.94 |
F-Score8
WACC6.7%
ROIC/WACC0.64
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.17%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%21.91%
EPS Next Y0.42%
EPS Next 2Y5.48%
EPS Next 3Y7.81%
EPS Next 5Y12.26%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-2.12%
Revenue Next Year-1.83%
Revenue Next 2Y0.64%
Revenue Next 3Y1.91%
Revenue Next 5Y3.26%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.14%
EBIT Next 3Y21.01%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%